{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:38:50Z","timestamp":1762900730515,"version":"3.41.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Scand J Trauma Resusc Emerg Med"],"DOI":"10.1186\/s13049-025-01438-8","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:20:49Z","timestamp":1751822449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Landiolol bolus application for tachycardic dysrhythmia in the prehospital EMS setting \u2013 An observational study of a novel concept"],"prefix":"10.1186","volume":"33","author":[{"given":"Felix","family":"Eibensteiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Krammel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kornfehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Veigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Domanovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Sulzgruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Schnaubelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"issue":"25","key":"1438_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7861\/clinmed.cme.20.1.3","volume":"20","author":"ID Kotadia","year":"2020","unstructured":"Kotadia ID, Williams SE, O\u2019Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med (Lond). 2020;20(1):43\u20137.","journal-title":"Clin Med (Lond)"},{"issue":"40","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC) endorsed by the association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2022;43(40):3997\u20134126.","journal-title":"Eur Heart J"},{"key":"1438_CR4","doi-asserted-by":"crossref","unstructured":"Sirichand S, Killu AM, Padmanabhan D, Hodge DO, Chamberlain AM, Brady PA, Kapa S, Noseworthy PA, Packer DL, Munger TM et al. Incidence of idiopathic ventricular arrhythmias: A Population-Based study. Circ Arrhythm Electrophysiol 2017;10(2).","DOI":"10.1161\/CIRCEP.116.004662"},{"issue":"1","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/CCM.0b013e3181fd6ad7","volume":"39","author":"JP Piccini","year":"2011","unstructured":"Piccini JP, Schulte PJ, Pieper KS, Mehta RH, White HD, Van de Werf F, Ardissino D, Califf RM, Granger CB, Ohman EM, et al. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*. Crit Care Med. 2011;39(1):78\u201383.","journal-title":"Crit Care Med"},{"key":"1438_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.resuscitation.2021.02.010","volume":"161","author":"J Soar","year":"2021","unstructured":"Soar J, B\u00f6ttiger BW, Carli P, Couper K, Deakin CD, Dj\u00e4rv T, Lott C, Olasveengen T, Paal P, Pellis T, et al. European resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115\u201351.","journal-title":"Resuscitation"},{"issue":"36","key":"1438_CR7","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, et al.: 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European society of cardiology (ESC), with the special contribution of the European heart rhythm association (EHRA) of the ESC. Endorsed by the European stroke organisation (ESO). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"key":"1438_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jcrc.2021.11.005","volume":"67","author":"JP Bedford","year":"2022","unstructured":"Bedford JP, Johnson A, Redfern O, Gerry S, Doidge J, Harrison D, Rajappan K, Rowan K, Young JD, Mouncey P, et al. Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: accounting for physiological status. J Crit Care. 2022;67:149\u201356.","journal-title":"J Crit Care"},{"issue":"1","key":"1438_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1378\/chest.15-0959","volume":"149","author":"AJ Walkey","year":"2016","unstructured":"Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: A Propensity-Matched cohort study. Chest. 2016;149(1):74\u201383.","journal-title":"Chest"},{"key":"1438_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2017.04.027","volume":"41","author":"M Balik","year":"2017","unstructured":"Balik M, Kolnikova I, Maly M, Waldauf P, Tavazzi G, Kristof J. Propafenone for supraventricular arrhythmias in septic shock\u2014Comparison to Amiodarone and Metoprolol. J Crit Care. 2017;41:16\u201323.","journal-title":"J Crit Care"},{"key":"1438_CR11","doi-asserted-by":"publisher","first-page":"104167","DOI":"10.1016\/j.amsu.2022.104167","volume":"80","author":"N Fatima","year":"2022","unstructured":"Fatima N, Mandava K, Khatoon F, Badar J, Begum SF, Narasimhan C, Daljeet K, Mohammed W. CLInical profile and side effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study. Annals Med Surg. 2022;80:104167.","journal-title":"Annals Med Surg"},{"issue":"1","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13054-021-03684-5","volume":"25","author":"L Drikite","year":"2021","unstructured":"Drikite L, Bedford JP, O\u2019Bryan L, Petrinic T, Rajappan K, Doidge J, Harrison DA, Rowan KM, Mouncey PR, Young D, et al. Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review. Crit Care. 2021;25(1):257.","journal-title":"Crit Care"},{"issue":"2","key":"1438_CR13","first-page":"327","volume":"61","author":"F Medi\u0107","year":"2022","unstructured":"Medi\u0107 F, Bakula M, Alfirevi\u0107 M, Bakula M, Muci\u0107 K, Mari\u0107 N. AMIODARONE AND THYROID DYSFUNCTION. Acta Clin Croat. 2022;61(2):327\u201341.","journal-title":"Acta Clin Croat"},{"issue":"12","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.amjcard.2019.09.008","volume":"124","author":"M Ruzieh","year":"2019","unstructured":"Ruzieh M, Moroi MK, Aboujamous NM, Ghahramani M, Naccarelli GV, Mandrola J, Foy AJ. Meta-Analysis comparing the relative risk of adverse events for Amiodarone versus placebo. Am J Cardiol. 2019;124(12):1889\u201393.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1438_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"J Brugada","year":"2019","unstructured":"Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomstr\u00f6m-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller G-P, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardiathe task force for the management of patients with supraventricular tachycardia of the European society of cardiology (ESC): developed in collaboration with the association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 2019;41(5):655\u2013720.","journal-title":"Eur Heart J"},{"issue":"5","key":"1438_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/AC.65.5.2056244","volume":"65","author":"F Gorre","year":"2010","unstructured":"Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 2010;65(5):565\u201370.","journal-title":"Acta Cardiol"},{"key":"1438_CR17","doi-asserted-by":"crossref","unstructured":"Wong GWK, Boyda HN, Wright JM. Blood pressure Lowering efficacy of beta-1 selective beta blockers for primary hypertension. Cochrane Database Syst Reviews 2016;(3).","DOI":"10.1002\/14651858.CD007451.pub2"},{"issue":"4","key":"1438_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/00005344-198307000-00023","volume":"5","author":"RJ Gorczynski","year":"1983","unstructured":"Gorczynski RJ, Shaffer JE, Lee RJ. Pharmacology of ASL-8052, a novel \u03b2-Adrenergic receptor antagonist with an ultrashort duration of action. J Cardiovasc Pharmacol. 1983;5(4):668\u201377.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1438_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2165\/00003088-199528030-00002","volume":"28","author":"D Wiest","year":"1995","unstructured":"Wiest D. Esmolol. A review of its therapeutic efficacy and Pharmacokinetic characteristics. Clin Pharmacokinet. 1995;28(3):190\u2013202.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1438_CR20","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1248\/cpb.40.1462","volume":"40","author":"S Iguchi","year":"1992","unstructured":"Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull (Tokyo). 1992;40(6):1462\u20139.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"2","key":"1438_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1067\/mcp.2000.108733","volume":"68","author":"H Atarashi","year":"2000","unstructured":"Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, Hayakawa H. Pharmacokinetics of Landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68(2):143\u201350.","journal-title":"Clin Pharmacol Ther"},{"key":"1438_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejps.2016.06.022","volume":"92","author":"G Krumpl","year":"2016","unstructured":"Krumpl G, Ulc I, Trebs M, Kadlecov\u00e1 P, Hodisch J. Pharmacokinetics and pharmacodynamics of two different Landiolol formulations in a healthy Caucasian group. Eur J Pharm Sci. 2016;92:64\u201373.","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"1438_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1253\/circrep.CR-19-0076","volume":"1","author":"N Iwahashi","year":"2019","unstructured":"Iwahashi N, Takahashi H, Abe T, Okada K, Akiyama E, Matsuzawa Y, Konishi M, Maejima N, Hibi K, Kosuge M, et al. Urgent control of rapid atrial fibrillation by Landiolol in patients with acute decompensated heart failure with severely reduced ejection fraction. Circ Rep. 2019;1(10):422\u201330.","journal-title":"Circ Rep"},{"key":"1438_CR24","doi-asserted-by":"crossref","unstructured":"Schnaubelt S, Eibensteiner F, Oppenauer J, Tihanyi D, Neymayer M, Brock R, Kornfehl A, Veigl C, Al Jalali V, Anders S et al. Hemodynamic and rhythmologic effects of Push-Dose Landiolol in critical Care-A retrospective Cross-Sectional study. Pharmaceuticals (Basel) 2023;16(2).","DOI":"10.3390\/ph16020134"},{"issue":"5","key":"1438_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bja.2021.11.016","volume":"128","author":"BW Johnston","year":"2022","unstructured":"Johnston BW, Chean CS, Duarte R, Hill R, Blackwood B, McAuley DF, Welters ID. Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis. Br J Anaesth. 2022;128(5):759\u201371.","journal-title":"Br J Anaesth"},{"issue":"11","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/europace\/eul107","volume":"8","author":"IC Van Gelder","year":"2006","unstructured":"Van Gelder IC, Hemels MEW. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. EP Europace. 2006;8(11):943\u20139.","journal-title":"EP Europace"},{"key":"1438_CR27","doi-asserted-by":"publisher","first-page":"100801","DOI":"10.1016\/j.lanepe.2023.100801","volume":"37","author":"D Gupta","year":"2024","unstructured":"Gupta D, Rienstra M, van Gelder IC, Fauchier L. Atrial fibrillation: better symptom control with rate and rhythm management. Lancet Reg Health - Europe. 2024;37:100801.","journal-title":"Lancet Reg Health - Europe"},{"issue":"10","key":"1438_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3390\/jcm13102951","volume":"13","author":"B Levy","year":"2024","unstructured":"Levy B, Slama M, Lakbar I, Maizel J, Kato H, Leone M, Okada M. Landiolol for treatment of New-Onset atrial fibrillation in critical care: A systematic review. J Clin Med. 2024;13(10):2951.","journal-title":"J Clin Med"},{"issue":"4","key":"1438_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00228-016-2176-0","volume":"73","author":"G Krumpl","year":"2017","unstructured":"Krumpl G, Ulc I, Trebs M, Kadlecov\u00e1 P, Hodisch J. Bolus application of Landiolol and esmolol: comparison of the Pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Eur J Clin Pharmacol. 2017;73(4):417\u201328.","journal-title":"Eur J Clin Pharmacol"},{"key":"1438_CR30","doi-asserted-by":"crossref","unstructured":"Bucci T, Proietti R, Lip GYH. Risk of death and thromboembolic events in patients with supraventricular arrhythmias admitted to the emergency department. EP Europace 2024;. Volume 26, Issue Supplement_1, May 2024, euae102.833","DOI":"10.1093\/europace\/euae102.833"},{"issue":"7","key":"1438_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1080\/10903127.2023.2283885","volume":"28","author":"LB Fornage","year":"2024","unstructured":"Fornage LB, Christine ON, DS R, WE R, LR S, Brown LH. Prehospital intervention improves outcomes for patients presenting in atrial fibrillation with rapid ventricular response. Prehospital Emerg Care. 2024;28(7):910\u20139.","journal-title":"Prehospital Emerg Care"},{"key":"1438_CR32","doi-asserted-by":"crossref","unstructured":"Nasoufidou A, Papazoglou AS, Stachteas P, Karagiannidis E, Samaras A, Alexiou S, Mourtzos MA, Kassimis G, Fragakis N. Intravenous Landiolol for rate control in supraventricular tachyarrhythmias in patients with left ventricular dysfunction: A systematic review and Meta-Analysis. J Clin Med 2024, 13(6).","DOI":"10.3390\/jcm13061683"},{"issue":"1","key":"1438_CR33","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1080\/07853890.2022.2098376","volume":"54","author":"M Heliste","year":"2022","unstructured":"Heliste M, Pettil\u00e4 V, Berger D, Jakob SM, Wilkman E. Beta-blocker treatment in the critically ill: a systematic review and meta-analysis. Ann Med. 2022;54(1):1994\u20132010.","journal-title":"Ann Med"},{"key":"1438_CR34","unstructured":"Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, McAuley D, Singer M, Lord J, Gates S et al. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial. JAMA 2023."},{"issue":"10","key":"1438_CR35","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, Cihl\u00e1\u0159 R, Borgstedt R, Biancofiore G, Guarracino F, Schober A, Trimmel H, Pernerstorfer T, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50(10):1622\u201334.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1438_CR36","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.hlc.2023.12.022","volume":"33","author":"S Schnaubelt","year":"2024","unstructured":"Schnaubelt S, Eibensteiner F, Sulzgruber P. Landiolol in septic Shock \u2014 No One-Size-Fits-All approach. Heart Lung Circulation. 2024;33(4):e31\u20132.","journal-title":"Heart Lung Circulation"},{"issue":"1","key":"1438_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13054-021-03470-3","volume":"25","author":"G Hariri","year":"2021","unstructured":"Hariri G, Urbina T, Mazerand S, Bige N, Baudel JL, Ait-Oufella H. Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients. Crit Care. 2021;25(1):33.","journal-title":"Crit Care"},{"issue":"1","key":"1438_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ehf2.13763","volume":"9","author":"V Ditali","year":"2022","unstructured":"Ditali V, Garatti L, Morici N, Villanova L, Colombo C, Oliva F, Sacco A. Effect of Landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ESC Heart Fail. 2022;9(1):766\u201370.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"1438_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12245-022-00453-1","volume":"15","author":"J Novotny","year":"2022","unstructured":"Novotny J, Klein MM, Haum M, Fichtner SR, Thienel MB. Prevalence of pathological arrhythmia in patients triaged to cardiac arrhythmia in the emergency department: a preliminary study. Int J Emerg Med. 2022;15(1):49.","journal-title":"Int J Emerg Med"},{"issue":"4","key":"1438_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1742-6723.12248","volume":"26","author":"G Smith","year":"2014","unstructured":"Smith G, McD Taylor D, Morgans A, Cameron P. Prehospital management of supraventricular tachycardia in victoria, australia: epidemiology and effectiveness of therapies. Emerg Med Australasia. 2014;26(4):350\u20135.","journal-title":"Emerg Med Australasia"},{"issue":"7","key":"1438_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1080\/10903127.2023.2283885","volume":"28","author":"LB Fornage","year":"2024","unstructured":"Fornage LB, O\u2019Neil C, Dowker SR, Wanta ER, Lewis RS, Brown LH. Prehospital intervention improves outcomes for patients presenting in atrial fibrillation with rapid ventricular response. Prehospital Emerg Care. 2024;28(7):910\u20139.","journal-title":"Prehospital Emerg Care"},{"key":"1438_CR42","doi-asserted-by":"publisher","unstructured":"Berkenbush M, Sherman N, Jain N, Cosmi P. Prehospital treatment of atrial fibrillation: infusion pump for bolus and infusion? Prehospital Emerg Care:1\u20134.2025;29(1):85-88. https:\/\/doi.org\/10.1080\/10903127.2024.2349745. Epub 2024 May 21.","DOI":"10.1080\/10903127.2024.2349745"},{"key":"1438_CR43","doi-asserted-by":"publisher","first-page":"132397","DOI":"10.1016\/j.ijcard.2024.132397","volume":"414","author":"J Ball","year":"2024","unstructured":"Ball J, Mahony E, Nehme E, Voskoboinik A, Hogarty J, Dawson LP, Horrigan M, Kaye DM, Stub D, Nehme Z. The burden of atrial fibrillation on emergency medical services: A population-based cohort study. Int J Cardiol. 2024;414:132397.","journal-title":"Int J Cardiol"},{"key":"1438_CR44","doi-asserted-by":"crossref","unstructured":"V\u00e1squez-Tirado GA, Quispe-Casta\u00f1eda CV, Meregildo-Rodr\u00edguez ED, Cuadra-Campos M, Segura-Plasencia NM, Arbayza-Avalos YK, Alva-Guarniz HN, Guzm\u00e1n-Aguilar WM, Zavaleta-Alaya P. Association of beta blockers and mortality in adults with septic shock: systematic review and meta-analysis of randomized clinical trial. Front Med 2024;Sep 24:11:1448573; eCollection 2024.","DOI":"10.3389\/fmed.2024.1448573"}],"container-title":["Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01438-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13049-025-01438-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13049-025-01438-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:20:51Z","timestamp":1751822451000},"score":1,"resource":{"primary":{"URL":"https:\/\/sjtrem.biomedcentral.com\/articles\/10.1186\/s13049-025-01438-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1186\/s13049-025-01438-8","relation":{},"ISSN":["1757-7241"],"issn-type":[{"value":"1757-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"for this study was given by the Ethical Committee of the Medical University of Vienna, Austria (No. 1442\/2021). The study protocol complies with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"Sebastian Schnaubelt has in the past received speakers\u2019 fees and research grants from AOP Health. However, AOP Health was not involved in the planning, analysis, or presentation of this study. He also declares to be member of the Advanced Life Support Science and Education Committee of the European Resuscitation Council. The rest of the authors declare to not have any (potential) conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}